Viruses and interferon: Mechanisms of interferon induction and strategies to escape interferon response;Virus et interferon: Mécanismes d'induction et stratégies d'échappement

Virologie

Volumn 12, Issue 3, 2008, Pages 159-173

  Bouttier, M ^a   Goncalves C ^b   Journo, C ^b   Letienne, J ^c   Pina M ^b   Vitour, D ^b  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c INRA and University of Auvergne   (France)

Author keywords

Innate immunity; Interferon; RIG I MDA5 helicases; Toll like receptor; Virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; VIRUS VACCINE;

CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENGUE VIRUS; EBOLA VIRUS; EPSTEIN BARR VIRUS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; INNATE IMMUNITY; NONHUMAN; ORTHOMYXOVIRUS; PARAMYXOVIRUS; REVIEW; ROTAVIRUS; VIRUS IMMUNITY;

EID: 53049099417     PISSN: 12678694     EISSN: None     Source Type: Journal    
DOI: 10.1684/vir.2008.0173     Document Type: Review

References (115)

1. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957 ; 147 : 258-67.
2. Delhaye S, Paul S, Sommereyns C, Van Pesch V, Michiels T. Les interférons de type I. Virologie 2006 ; 10 : 167-78.
3. Ank N, West H, Paludan SR. IFN-lambda : novel antiviral cytokines. J Interferon Cytokine Res 2006 ; 26 : 373-9.
4. Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-lambda) is expressed in tissue dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008 ; 4 ; (e1000017).
5. Kawai T, Akira S. Antiviral signaling through pattern recognition receptors. J Biochem (Tokyo) 2007 ; 141 : 137-45.
6. Thompson AJ, Locarnini SA. Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol Cell Biol 2007 ; 85 : 435-45.
7. Unterholzner L, Bowie AG. The interplay between viruses and innate immune signaling : Recent insights and therapeutic opportunities. Biochem Pharmacol 2008 ; 75 : 589-602.
8. Eisenacher K, Steinberg C, Reindl W, Krug A. The role of viral nucleic acid recognition in dendritic cells for innate and adaptive antiviral immunity. Immunobiology 2008 ; 212 : 701-14.
9. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006 ; 124 : 783-801.
10. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005 ; 17 : 1-14.
11. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by Toll-like-receptor 3. Clin Microbiol Rev 2008 ; 21 : 13-25.
12. O'Neill LA, Bowie AG. The family of five : TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007 ; 7 : 353-64.
13. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 ; 413 : 732-8.
14. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003 ; 301 : 640-3.
15. Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toil-like receptor signaling. Nat Immunol 2006 ; 7 : 1023-5.
16. Honda K, Takaoka A, Taniguchi T. Type I inteferon gene in duction by the interferon regulatory factor family of transcription factors. Immunity 2006 ; 25 : 349-60.
17. Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and independent antiviral response. Nature 2006 ; 439 : 208-11.
18. Hacker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006 ; 439 : 204-7.
19. Zhao T, Yang L, Sun Q, et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol 2007 ; 8 : 592-600.
20. Ryzhakov G, Randow F. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1 binding domain with NAP1 and TANK. EMBO J 2007 ; 26 : 3180-90.
21. Panne D, Maniatis T, Harrison SC. An atomic model of the interferon-beta enhanceosome. Cell 2007 ; 129 : 1111-23.
22. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007 ; 282 : 15325-9.
23. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007 ; 315 : 1274-8.
24. Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005 ; 434 : 772-7.
25. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC. Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 2004 ; 11 : 1060-7.
26. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004 ; 10 : 1366-73.
27. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting Edge : Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007 ; 178 : 3368-72.
28. Kawai T, Sato S, Ishii KJ, et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004 ; 5 : 1061-8.
29. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 ; 408 : 740-5.
30. Hochrein H, Schlatter B, O'Keeffe M, et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc Natl Acad Sci USA 2004 ; 101 : 11416-21.
31. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004 ; 5 : 730-7.
32. Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind.the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004 ; 101 : 17264-9.
33. Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005 ; 23 : 19-28.
34. Gack MU, Shin YC, Joo CH, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007 ; 446 : 916-20.
35. Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 2007 ; 104 : 7500-5.
36. Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006 ; 441 : 101-5.
37. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006 ; 314 : 997-1001.
38. Hornung V, Ellegast J, Kim S, et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006 ; 314 : 994-7.
39. Plumet S, Herschke F, Bourhis JM, Valentin H, Longhi S, Gerlier D. Cytosolic 5′-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS ONE 2007 ; 2 : e279.
40. Loo YM, Fornek J, Crochet N, et al. Distinct Rig-I and Mda5 Signaling by Rna Viruses in Innate Immunity. J Virol 2008 ; 82 : 335-45.
41. Saito T, Hirai R, Loo YM, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci USA 2007 ; 104 : 582-7.
42. Vitour D, Meurs EF. Regulation of interferon production by RIG-I and LGP2 : a lesson in self-control. Sci STKE 2007 2007 : 20.
43. Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005 ; 437 : 1167-72.
44. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus triggered IFN-beta signaling. Mol Cell 2005 ; 19 : 727-40.
45. Kawai T, Takahashi K, Sato S, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 2005 ; 6 : 981-8.
46. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005 ; 122 : 669-82.
47. Sun Q, Sun L, Liu HH, et al. The Specific and Essential Role of MAVS in Antiviral Innate Immune Responses. Immunity 2006 ; 24 : 633-42.
48. Moore CB, Bergstralh DT, Duncan JA, et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008.
49. Saha SK, Pietras EM, He JQ, et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 2006 ; 25 : 3257-63.
50. Lin R, Lacoste J, Nakhaei P, et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 2006 ; 80 : 6072-83.
51. Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box, helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 2005 ; 175 : 2851-8.
52. Komuro A, Horvath CM. RNA and virus-independent inhibition of antiviral signaling by RNA-helicase LGP2. J Virol 2006 ; 80 : 12332-42.
53. Venkataraman T, Valdes M, Elsby R, et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007 ; 178 : 6444-55.
54. Cheng G, Zhong J, Chung J, Chisari FV. Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci USA 2007 ; 104 : 9035-40.
55. Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007 ; 448 : 501-5.
56. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor : characterization and molecular cloning. Cell 1994 ; 77 : 391-400.
57. Valentino L, Pierre J. JAK/STAT signal transduction : regulators and implication in hematological malignancies. Biochem Pharmacol 2006 ; 71 : 713-21.
58. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005 ; 5 : 375-86.
59. De Veer MJ, Holko M, Frevel M, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001 ; 69 : 912-20.
60. Meurs E, Chong K, Galabru J, et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990 ; 62 : 379-90.
61. Williams BR. PKR ; a sentinel kinase for cellular stress. Oncogene 1999 ; 18 : 6112-20.
62. Pichlmair A, Reis e Sousa C. Innate recognition of viruses. Immunity 2007 ; 27 : 370-83.
63. Smith EJ, Marie I, Prakash A, Garcia-Sastre A, Levy DE. IRF3 and IRF7 phosphorylation in virus-infected cells does not require doublestranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E 3L protein. J Biol Chem 2001 ; 276 : 8951-7.
64. Gilfoy FD, Mason PW. West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR. J Virol 2007 ; 81 : 11148-58.
65. Silverman RH. Fascination with 2-5A-dependent RNase : a unique enzyme that functions in interferon action. J Interferon Res 1994 ; 14 : 101-4.
66. Malathi K, Dong B, Gale Jr. M, Silverman RH. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007 ; 448 : 816-9.
67. Haller O, Kochs G. Interferon-induced mx proteins : dynamin-like GTPases with antiviral activity. Traffic 2002 ; 3 : 710-7.
68. Guo J, Hui DJ, Merrick WC, Sen GC. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 2000 ; 19 : 6891-9.
69. Hui DJ, Bhasker CR, Merrick WC, Sen GC. Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 2003 ; 278 : 39477-82.
70. Borden EC, Sen GC, Uze G, et al. Interferons at age 50 : past, current and future impact on biomedicine. Nat Rev Drug Discov 2007 ; 6 : 975-90.
71. Haller O, Kochs G, Weber F. The interferon response circuit : induction and suppression by pathogenic viruses. Virology 2006 ; 344 : 119-30.
72. Galligan CL, Murooka TT, Rahbar R, Baig E, Majchrzak-Kita B, Fish EN. Interferons and viruses : signaling for supremacy. Immunol Res 2006 ; 35 : 27-40.
73. Haller O, Kochs G, Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 2007 ; 18 : 425-33.
74. Weber F, Haller O. Viral suppression of the interferon system. Biochimie 2007 ; 89 : 836-42.
75. Stack J, Haga IR, Schroder M, et al. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 2005 ; 201 : 1007-18.
76. Harte MT, Haga IR, Maloney G, et al. The poxvirus protein targets Toll-like A52R receptor signaling complexes to suppress host defense. J Exp Med 2003 ; 197 : 343-51.
77. Li K, Foy E, Ferreon JC, et al. Immune e vasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005 ; 102 : 2992-7.
78. Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007 ; 45 : 102-10.
79. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale-Jr. M, Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 p rotein of influenza A virus. J Virol 2007 ; 81 : 514-24.
80. Childs K, Stock N, Ross C, et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 2007 ; 359 : 190-200.
81. Chen Z, Benureau Y, Rijnbrand R, et al. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 2007 ; 81 : 964-76.
82. Yang Y, Liang Y, Qu L, et al. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci USA 2007 ; 104 : 7253-8.
83. Unterstab G, Ludwig S, Anton A, et al. Viral targeting of the interferon-beta-inducing Traf family member-associated NF-kappaB activator (TANK)-binding kinase-1. Proc Natl Acad Sci USA 2005 ; 102 : 13640-5.
84. Lubyova B. Kellu m MJ, Frisancho AJ, Pitha PM. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 2004 ; 279 : 7643-54.
85. Lin R, Genin P, Mamane Y, et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene 2001 ; 20 : 800-11.
86. Barro M, Patton JT. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc Natl Acad Sci USA 2005 ; 102 : 4114-9.
87. Melroe GT, Silva L, Schaffer PA, Knipe DM. Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci : Potential role in blocking IFN-beta induction. Virology 2007 ; 360 : 305-21.
88. Hahn AM, Huye LE, Ning S, Webster-Cyriaque J, Pagano JS. Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J Virol 2005 ; 79 : 10040-52.
89. Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 1995 ; 81 : 551-60.
90. Li S, Labrecque S, Gauzzi MC, et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 1999 ; 18 : 5727-37.
91. Jones M, Davidson A, Hibbert L, et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 2005 ; 79 : 5414-20.
92. Bode JG, Ludwig S, Ehrhardt C, et al. IFN-alpha antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling-3. FASEB J 2003 ; 17 : 488-90.
93. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MM. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 1999 ; 285 : 107-10.
94. He B, Gross M, Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997 ; 94 : 843-8.
95. Goodman AG, Smith JA, Balachandran S, et al. The cellular protein P58IPK regulates influenza virus, mRNA translation and replication through a PKR-mediated mechanism. J Virol 2007 ; 81 : 2221-30.
96. Marques JT, Devosse T, Wang D, et al. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 2006 ; 24 : 559-65.
97. Schlee M, Hornung V, Hartmann G. siRNA and isRNA : two edges of one sword. Mol Ther 2006 ; 14 : 463-70.
98. Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007 ; 449 : 919-22.
99. Barral PM, Morris on JM, Drahos J, et al. MDA-5 is cleaved in poliovirus-infected cells. J Virol 2007 ; 81 : 3677-84.
100. Otsuka M, Kato N, Moriyama M, et al. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 2005 ; 41 : 1004-12.
101. Brzozka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist : phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 2005 ; 79 : 7673-81.
102. Ronco LV, Karpova AY, Vidal M, Howley PM. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 1998 ; 12 : 2061-72.
103. Alff PJ, Gavrilovskaya IN, Gorbunova E, et al. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 2006 ; 80 : 9676-86.
104. Saira K, Zhou Y, Jones C. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interfer on response factor 3 and, consequently, inhibits beta interferon promoter activity. J Virol 2007 ; 81 : 3077-86.
105. Cardenas WB, Loo YM, Gale Jr. M, et al. Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling. J Virol 2006 ; 80 : 5168-78.
106. Jennings S, Martinez-Sobrido L, Garcia-Sastre A, Weber F, Kochs G. Thogoto virus ML protein suppresses IRF3 function. Virology 2005 ; 331 : 63-72.
107. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 2004 ; 116 : 541-50.
108. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in celt culture is ass ociated with suppression of alpha/beta interferon. J Virol 1999 ; 73 : 9891-8.
109. Alcami A, Symons JA, Smith GL. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 2000 ; 74 : 11230-9.
110. Brzozka K, Finke S, Conzelmann KK. Inhibition of interferon signaling by rabies virus phosphoprotein P : activation-dependent binding of STAT1 and STAT2. J Virol 2006 ; 80 : 2675-83.
111. Caignard G, Guerbois M, Labernardiere JL, et al. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 2007 ; 368 : 351-62.
112. Garcin D, Marq JB, Iseni F, Martin S, Kolakofsky D. A short peptide at the amino terminus of the Sendai virus C protein acts as an independent element that induces STAT1 instability. J Virol 2004 ; 78 : 8799-811.
113. Precious B, Young DF, Andrejeva L, Goodbourn S, Randall RE. In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 2005 ; 86 : 151-8.
114. Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA- activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1992 ; 66 : 1943-50.
115. Roy S, Katze MG, Parkin NT, Edery I, Hovanessian AG, Sonenberg N. Control of the interferon- induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 1990 ; 247 : 1216-9.